Get started
Author

Najah Harouki

Vascular Smooth Muscle Mineralocorticoid Receptor Contributes to Coronary and Left Ventricular Dysfunction After Myocardial Infarction
2016 · Alexandre Gueret, Najah Harouki, et al. · Hypertension · 93
PDF
The IL-1β Antibody Gevokizumab Limits Cardiac Remodeling and Coronary Dysfunction in Rats With Heart Failure
2017 · Najah Harouki, Lionel Nicol, et al. · JACC Basic to Translational Science · 66
PDF
Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice
2015 · Clothilde Roche, Marie Besnier, et al. · American Journal of Physiology-Heart and Circulatory Physiology · 56
Nitrogen Dioxide Inhalation Exposures Induce Cardiac Mitochondrial Reactive Oxygen Species Production, Impair Mitochondrial Function and Promote Coronary Endothelial Dysfunction
2020 · Ahmed Karoui, Clément Crochemore, et al. · International Journal of Environmental Research and Public Health · 34
PDF
Mineralocorticoid Receptor Blockade with Finerenone Improves Heart Function and Exercise Capacity in Ovariectomized Mice
2021 · Marie Pieronne-Deperrois, Alexandre Guéret, et al. · ESC Heart Failure · 29
PDF
Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice
2015 · Clothilde Roche, Dominique Guerrot, et al. · Prostaglandins & Other Lipid Mediators · 29
Improvement of left ventricular diastolic function induced by β-blockade
2011 · Yuehua Fang, Lionel Nicol, et al. · Journal of Molecular and Cellular Cardiology · 28
Infliximab improves endothelial dysfunction in a mouse model of antiphospholipid syndrome: Role of reduced oxidative stress
2015 · Ygal Benhamou, Sébastien Miranda, et al. · Vascular Pharmacology · 25
Transient Heart Rate Reduction Improves Acute Decompensated Heart Failure-Induced Left Ventricular and Coronary Dysfunction
2021 · Nicolas Peschanski, Najah Harouki, et al. · ESC Heart Failure · 7
PDF
Dual ETA‐ETB receptor antagonism improves metabolic syndrome‐induced heart failure with preserved ejection fraction
2025 · Francesca Lockwood, Marianne Lachaux, et al. · Fundamental and Clinical Pharmacology · 6
PDF
Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer
2026 · Francois Ghiringhelli, Richard Kim, et al. · Journal for ImmunoTherapy of Cancer · 3
PDF
Abstract CT133: A phase 1b multicenter study of anti-TIM3 (S095018/Sym023) in combination with anti-PD1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer
2024 · Francois Ghiringhelli, Richard Kim, et al. · Cancer Research · 3
0542 : Vascular smooth muscle mineralocorticoid receptor contributes to coronary and left ventricular dysfunction after myocardial infarction
2016 · Alexandre Gueret, Najah Harouki, et al. · Archives of Cardiovascular Diseases Supplements · 3
PDF
Sympathetic Nerve Activity and Baroreflex are Strongly Altered in a Context of Severe Hypertension Using the Spontaneously Hypertensive Rat Model Associated with Chronic Reduction of Nitric Oxide
2021 · Christine Vayssettes-Courchay, Jonathan Melka, et al. · International Journal of Hypertension · 2
PDF
Correction: Karoui et al. Nitrogen Dioxide Inhalation Exposures Induce Cardiac Mitochondrial Reactive Oxygen Species Production, Impair Mitochondrial Function and Promote Coronary Endothelial Dysfunction. Int. J. Environ. Res. Public Health 2020, 17, 5526
2025 · Ahmed Karoui, Clément Crochemore, et al. · International Journal of Environmental Research and Public Health · 1
PDF
0316 : Vascular smooth muscle mineralocorticoid receptor contributes to coronary and left ventricular dysfunction after myocardial infarction
2015 · Alexandre Gueret, Najah Harouki, et al. · Archives of Cardiovascular Diseases Supplements · 1
Early and delayed IL-1 beta modulating antibody, gevokizumab, treatments limit cardiac remodeling and reverse coronary endothelial dysfunction following myocardial infarction injury in diabetic rats
2013 · N. Harouki, L. Nicol, et al. · European Heart Journal · 1
Relevant preclinical model of heart failure in rat: Impact of myocardial infarction and hypertension
2019 · M. Isabelle, N. Harouki, et al. · Archives of Cardiovascular Diseases Supplements
PDF
Validation of a preclinical model of heart failure with reduced ejection fraction by a dual angiotensin receptor-neprilysin inhibitor and an angiotensin-converting enzyme inhibitor
2019 · M. Isabelle, N. Harouki, et al. · Archives of Cardiovascular Diseases Supplements
PDF
Reproducibility and reliability of echocardiography in a preclinical model of myocardial infarction in rodent
2019 · M. Isabelle, N. Harouki, et al. · Archives of Cardiovascular Diseases Supplements
PDF
Improved metabolic syndrome-related right and left ventricular dysfunction by the dual ET A -ET B receptor antagonist macitentan
2017 · M. Lachaux, N. Harouki, et al. · Archives of Cardiovascular Diseases Supplements
Selenoprotein T gene-therapy using rAAV8 improves cardiac function and remodeling in rats with heart failure through a seleniumdependent pathway
2017 · I. Boukhalfa, N. Harouki, et al. · Archives of Cardiovascular Diseases Supplements
0378 : Time course of cardiac dysfunction in experimental acute decompensation of chronic heart failure
2016 · Marianne Lachaux, Nicolas Peschanski, et al. · Archives of Cardiovascular Diseases Supplements
PDF
Effet de l'inhibition de l'IL-1B par le Gevokizumab sur les dysfonctions cardiaque et vasculaire dans un modèle d'ischémie-reperfusion chez le rat Wistar et le rat GK diabétique
2016 · Najah Harouki
Selenoprotein T: A new promising target for the treatment of myocardial infarction and heart failure
2015 · Inès Boukhalfa, Najah Harouki, et al. · CRC Press eBooks
Works count: 37
Citation count: 387
H-index: 8
I10-index: 8
Year
Topic
Type